Free Trial
→ Buffett’s $325 Billion Cash Problem — Solved by Gold? (From Golden Portfolio) (Ad) Free KPRX Stock Alerts

Kiora Pharmaceuticals (KPRX) SEC Filings & 10K Form

Kiora Pharmaceuticals logo
$2.86 +0.00 (+0.14%)
Closing price 07/3/2025 01:00 PM Eastern
Extended Trading
$2.88 +0.02 (+0.70%)
As of 07/3/2025 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Kiora Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/04/2025
1:34 PM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
6:00 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
5:59 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2025
6:02 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
9:00 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form DEF 14A
04/02/2025
7:10 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:11 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:14 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:15 PM		Hollander David (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:15 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Parsons Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:16 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:28 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Strem Brian M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:28 PM		Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:29 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
5:55 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2025
5:57 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2025
6:00 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
10:39 AM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/10/2025
7:38 AM		HIRSCHMAN ORIN (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/15/2025
4:22 PM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:17 PM		KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/14/2024
3:53 PM		KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/14/2024
3:32 PM		Alyeska Investment Group, L.P. (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SC 13G
11/13/2024
4:34 PM		KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
11/08/2024
6:00 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
6:01 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
6:00 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:32 AM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:02 AM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
12:00 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
2:45 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:17 PM		KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
6:01 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:01 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:02 AM		KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:KPRX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
The robotics revolution is here. And it's set to impact everything from how we manufacture goods to how we ...
Weiss Ratings | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored
Gold: Now legal tender in many states
The perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...
Stansberry Research | Sponsored
Revealed: NEW A.I. revolution (nobody is talking about)
Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...
Behind the Markets | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored